News

05 Apr 2018

Characterization of iPSCs by Immunocytochemistry

As part of our contract services at REPROCELL, we offer induced pluripotent stem cell (iPSC) characterization by immunocytochemistry (ICC).
Read More >>

27 Mar 2018

The Benefits of Human Tissue to Drug Discovery and Development

With our help, human tissue research can be a reliable and valued component of the drug discovery process.
Read More >>

14 Mar 2018

Patient-derived tumor organoids recapitulated clinical treatments

Recently, researchers from The Institute of Cancer Research, London and from the Department of Medicine, The Royal Marsden NHS Trust, London, UK, demonstrated that 3D patient-derived tumor organoids can be used to efficiently screen candidate cancer treatments.
Read More >>

08 Nov 2017

REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

Press release: REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services
Read More >>

1 2 3 4 >>

Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services

21/06/2018

REPROCELL’s BioServe and Biopta tissue procurement networks combine to create a new service isolating human primary cells.

REPROCELL Human Tissue Networks

REPROCELL, the leading human tissue research company, is further expanding its range of human tissue services provided to the pharmaceutical industry. For over 16 years, its BioServe and Biopta brands have been recognized experts in accessing ethically-sourced human biospecimens. Through its new cell culture facilities in Maryland and Glasgow, UK, REPROCELL sources tissues and isolates primary cells from tissues including blood and solid tissues. REPROCELL can access both healthy donors and a wide range of diseases (e.g. COPD, Asthma, Psoriasis, Inflammatory bowel disease, etc.). REPROCELL has over 600,000 samples in its biorepository and also offers custom collections from its global tissue network.

 

Human primary cells: more relevant than animal cells or immortalized cell lines

We provide our clients with customized projects to generate primary cells of value to your research programs. By using human cells, important physiological properties of the original tissue are retained and the prediction of human responses to drugs is superior to tests using immortalized cell lines or animal cells.

 

Find out more »

 

Or contact info-emea@reprocell.com for more information and to talk about your requirements with our experts.


Chirag Tawde

Written by Chirag Tawde

Sales Director EMEA

Live chat by BoldChat